In the pursuit of cognitive wellbeing and longevity, Bacopa monnieri, also known as Brahmi, has been revered for centuries in traditional Ayurvedic medicine for its positive brain health benefits.
Ayurvedic herbal medicine practitioners classify Bacopa as a medhyarasayana, a treatment for improving memory and intellect (‘medhya’).
What is BacoMind?
Boasting an ever-expanding body of research, BacoMind® is a premium proprietary extract of Brahmi that consumers can trust for quality and efficacy. It is a standardised extract derived from the Bacopa monnieri plant produced using a unique and patented extraction process that ensures the preservation of the herb’s important active compounds.
BacoMind® is the only Bacopa monnieri that contains a signature profile of nine different bioactives — bacopasaponin C, bacopaside I, bacopaside II, bacoside A3, beta-sitosterol-D-glucoside, jujubogenin isomer of bacopasaponin C, bacosine, apigenin and luteolin.
Enhancing Cognitive Function
Numerous scientific studies have demonstrated BacoMind's positive impact on cognitive function. Research has shown that BacoMind® supplementation can improve memory, attention, and overall cognitive performance. A randomised, double-blind, placebo-controlled trial found that participants who received BacoMind® showed significant improvements in their working memory and attention compared to those who received a placebo.
Protecting Against Age-Related Cognitive Decline
One of the most intriguing aspects of BacoMind® is its potential to protect against age-related cognitive decline. Studies have suggested that Bacopa may help reduce the risk of neurodegenerative disorders such as Alzheimer's disease (AD). Bacopa monnieri is believed to exert its neuroprotective effects through various mechanisms, including antioxidant activity, modulation of neurotransmitters, and anti-inflammatory properties and has shown a promising inhibitory role against Tau-mediated toxicity (deposits in the brain, associated with AD).
In a study of elderly patients consuming BacoMind® for just 12 weeks, it was demonstrated it could improve cognitive performance and reduce levels of anxiety and depression. Another study further backed these findings up, showing that BacoMind® supplementation could also improve memory and cognitive function in healthy older adults.
Alleviating Stress and Anxiety
One of the biggest chronic risk factors to mental health and wellbeing is stress and anxiety.
The ability to support perceived stress and anxiety is a highly desirable secondary function of BacoMind® that can help to wholistically contribute to brain health.
A double-blind, placebo-controlled study showed that participants who received BacoMind® experienced significant reductions in anxiety levels compared to the placebo group. Bacopa’s anxiolytic properties are thought to be attributed to its ability to modulate the pathways of certain positive mood neurotransmitters, such as serotonin.
Longevity and Brain Health
Maintaining brain and nerve health is crucial for overall longevity. The potential BacoMind® has shown in promoting brain health has led to speculation about its impact on longevity. While research specifically linking BacoMind® to longevity is limited, one could argue that Bacopa’s ability to enhance cognitive function, protect against age-related cognitive decline, and reduce stress and anxiety could contribute to a better quality of life and potentially increase longevity.
Why Choose BacoMind®?
BacoMind® is the world-leading, scientifically validated extract derived from Bacopa Monnieri. It has an evidenced-backed portfolio of research for its therapeutic use in improving memory, attention, and overall cognitive performance, reducing stress and anxiousness, as well as showing potential to protect against age-related cognitive decline.
BacoMind® offers a natural solution for those seeking to optimise brain function.
References
Dethe S, et al. Elucidation of Molecular Mechanism(s) of Cognition Enhancing Activity of Bacomind®: A Standardized Extract of Bacopa Monnieri. Pharmacogn Mag. 2016 Jul;12(Suppl 4):S482-S487.
Pravina K, et al. Safety evaluation of BacoMind in healthy volunteers: a phase I study. Phytomedicine. 2007 May;14(5):301-8.
Roodenrys S, et al. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Journal of Alternative and Complementary Medicine. 2002;8(6), 707-713.
Calabrese C, et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety and depression in the elderly: A randomized, double-blind, placebo-controlled trial. J Altern Complement Med 2008;14(6):707–713.
Stough C, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology. 2008;156(4):481-484.
Rao RV, et al. Natural products in the prevention and treatment of Alzheimer's disease. Current Topics in Medicinal Chemistry. 2008;19(21):1866-1882.
Aguiar S, et al. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013 Aug;16(4):313-26.
Shalini VT, et al. Neuroprotection with Bacopa monnieri-A review of experimental evidence. Mol Biol Rep. 2021 Mar;48(3):2653-2668.
Dubey T, et al. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease. Arch Biochem Biophys. 2019 Nov 15;676:108153.
Russo A, et al. Free radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damage. Phytotherapy Research. 2003;17(8):870-875.
